VeraSci is attending the 2021 American Society for Clinical Psychopharmacology! The 2021 ASCP Annual Meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that will discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.

Luca Pani, Vice President, Regulatory Strategy and Market Access Innovation for VeraSci, will be participating in the Keynote Plenary (Sustainable Innovation in Pharmaceutical Products R&D: Linking Registration to Reimbursement).

Our team would love the opportunity to meet with you virtually to discuss how VeraSci can support your next clinical trial.

Contact us:

ASCP 2021 Meeting Request

  • :
  • MM slash DD slash YYYY